.Regeneron is back along with lasting consequence for its own LAG-3 prevention and also PD-1 inhibit...
.AstraZeneca has shared an early look at the performance of its in-house antibody-drug conjugate (AD...
.After introducing a stage 3 launch based upon beneficial midstage outcomes, iTeos and also GSK are ...
.The FDA needs to be much more open as well as collective to discharge a surge in approvals of unusu...
.It's an extraordinarily hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bi...
.Atea Pharmaceuticals' antiviral has actually fallen short another COVID-19 test, however the biotec...
.Neurocrine Biosciences' schizophrenia plan pivot has actually fallen short. The biotech was actuall...
.Sanofi has made an overdue entry to the radioligand party, paying out 100 million europeans ($ 110 ...
.After F2G's 1st effort to get a brand-new lesson of antifungal to market was derailed by the FDA, t...
.Moderna has vowed to cut R&D spending by $1.1 billion by 2027. The decision to retract the budge...